What is the evidence for the accuracy of Quantitative Baseline (QB) testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evidence for Accuracy of Quantitative Baseline (QB) Testing

Direct Answer

The QbTest demonstrates poor to moderate diagnostic accuracy for ADHD and should not be used as a stand-alone screening or diagnostic tool, but may provide value as an adjunct to comprehensive clinical assessment. 1

Diagnostic Performance

Sensitivity and Specificity

The most recent and comprehensive meta-analysis reveals concerning limitations in QbTest accuracy 1:

  • QbTest Total scores show acceptable sensitivity (0.78 [95% CI: 0.69-0.85]) but only moderate specificity (0.70 [0.57-0.81]) 1
  • QbTest subscales perform worse, with low-to-moderate sensitivity ranging from 0.48 to 0.65 and moderate-to-good specificity from 0.65 to 0.83 1
  • Area Under Curve (AUC) scores indicate moderate-to-acceptable discriminative ability at best: Q-Total (0.72), Q-Activity (0.67), Q-Inattention (0.66), and Q-Impulsivity (0.59) 1

Contradictory Evidence on Clinical Populations

In adolescents with neurodevelopmental disorders, the QbTest fails to differentiate ADHD from other conditions, with AUC scores ranging from 0.48-0.64 (essentially random to poor validity) 2. This study specifically warns clinicians about the "dubious discriminating power" when used in populations with high rates of comorbid neurodevelopmental conditions 2.

A pediatric retrospective study of 1,274 children and adolescents found similarly poor diagnostic accuracy, with sensitivity ranging 22-50%, specificity 79-96%, positive predictive values 40-95%, and negative predictive values 24-66% 3.

Clinical Utility Considerations

When QbTest May Add Value

The QbTest can produce efficiencies in the assessment pathway and reduce time to diagnosis when used as an adjunct to full clinical assessment 1. One study demonstrated that objective QbTest results identified clinically significant medication effects in 54% of patients who subjectively reported no clinical improvement 4.

Critical Limitations

  • QbTest scores correlate with IQ, meaning cognitive ability confounds interpretation 2
  • The test cannot differentiate ADHD from other neurodevelopmental conditions in complex clinical populations 2
  • Weak correlations exist between objective QbTest measures and subjective rating scales, suggesting they measure different psychological constructs 4

Practical Recommendations

Do not use QbTest as:

  • A stand-alone diagnostic tool 1
  • A screening instrument 1
  • A triage system for accepting individuals onto waiting lists 1

Consider QbTest only as:

  • An adjunct to comprehensive clinical assessment that includes detailed history, structured diagnostic interviews, and collateral information 1
  • An objective measure to supplement subjective reports, particularly when monitoring treatment response in patients who have difficulty reporting effects 4

Common Pitfalls

The most significant pitfall is over-relying on QbTest results in isolation, particularly in populations with high rates of comorbid neurodevelopmental disorders where the test's discriminative ability approaches chance levels 2. Clinicians must recognize that acceptable sensitivity and specificity in research settings translate to inadequate positive and negative predictive values in real-world clinical practice, especially when ADHD prevalence varies 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.